» Articles » PMID: 17574979

Spatial Heterogeneity of Low-grade Gliomas at the Capillary Level: a PET Study on Tumor Blood Flow and Amino Acid Uptake

Overview
Journal J Nucl Med
Specialty Nuclear Medicine
Date 2007 Jun 19
PMID 17574979
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Many low-grade gliomas (World Health Organization grade II) respond to chemotherapy. Cerebral blood flow (CBF) and microvessel density may be critical for drug delivery. We used PET with (18)F-fluoro-ethyl-l-tyrosine (FET) to measure the spatial distribution of the amino acid carrier, which is located at the brain capillaries, and (15)O-H(2)O to measure tumor CBF.

Methods: Seventeen patients with low-grade glioma were studied. Region-of-interest (ROI) analysis was used to quantify tumor tracer uptake, which was normalized to cerebellar uptake (tumor-to-cerebellum ratio). "Active" tumor was defined as tumor having a radioactivity concentration that was at least 110% of the cerebellar activity. This threshold provided measures of active tumor volume, global and peak tumor CBF, and (18)F-FET uptake. Trace ROIs were applied to create voxelwise profiles of CBF and (18)F-FET uptake across tumor and brain. Standard MRI sequences were used for spatial correlations.

Results: Fourteen of 17 tumors showed increased global CBF and (18)F-FET uptake. Active tumor volumes ranged between 3 and 270 cm(3) for (18)F-FET and between 1 and 41 cm(3) for CBF. Global (18)F-FET uptake in tumors corresponded to CBF increases (Spearman rank rho = 0.771, P < 0.01). The volumes of increased CBF and (18)F-FET uptake spatially coincided and were also correlated (rho = 0.944, P < 0.01). Trace ROIs showed that irrespective of increased (18)F-FET uptake at the tumor periphery, CBF increases were more confined to the tumor center. Within individual tumors, spatial heterogeneity was present. Particular tumors infiltrating the corpus callosum showed low CBF and (18)F-FET uptake in this tumor region. The patterns observed with PET were not reflected on MRI of the tumors, all of which presented as homogeneous non-gadolinium-enhancing lesions.

Conclusion: Low-grade gliomas are heterogeneous tumors with regard to the distribution of amino acid uptake and CBF. Both are coupled in the tumor center. At the tumor periphery, where tumor infiltration of surrounding brain occurs, CBF may be low irrespective of increased (18)F-FET uptake. An ongoing study is investigating the effect of chemotherapy on these observations.

Citing Articles

Exploring the association of glioma tumor residuals from incongruent [F]FET PET/MR imaging with tumor proliferation using a multiparametric MRI radiomics nomogram.

Li X, Cheng Y, Han X, Cui B, Li J, Yang H Eur J Nucl Med Mol Imaging. 2023; 51(3):779-796.

PMID: 37864593 DOI: 10.1007/s00259-023-06468-x.


Extracardiac findings with increased perfusion during clinical O-15-HO PET/CT myocardial perfusion imaging: A case series.

Jochumsen M, Overgaard D, Holm Vendelbo M, Madsen M, Tolbod L, Gormsen L J Nucl Cardiol. 2023; 30(4):1458-1468.

PMID: 36600173 PMC: 9812748. DOI: 10.1007/s12350-022-03156-5.


Three-Dimensional Arterial Spin Labeling-Guided Sub-Volume Segmentation of Radiotherapy in Adult Non-Enhancing Low-Grade Gliomas.

Zhu Z, Gong G, Wang L, Su Y, Lu J, Yin Y Front Oncol. 2022; 12:914507.

PMID: 35860561 PMC: 9291222. DOI: 10.3389/fonc.2022.914507.


Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response.

Fu T, Dai L, Wu S, Xiao Y, Ma D, Jiang Y J Hematol Oncol. 2021; 14(1):98.

PMID: 34172088 PMC: 8234625. DOI: 10.1186/s13045-021-01103-4.


Multimodal Imaging of Nonenhancing Glioblastoma Regions.

John F, Robinette N, Amit-Yousif A, Bosnyak E, Barger G, Shah K Mol Imaging. 2019; 18:1536012119885222.

PMID: 31736437 PMC: 6862774. DOI: 10.1177/1536012119885222.